Loading clinical trials...
Loading clinical trials...
Neural Dimensions of Attention Bias Modification for Transdiagnostic Anxiety
This project seeks to identify neural mechanisms underlying the tendency for anxious individuals to pay more attention to threatening information than to other types of information. A computerized treatment designed to train individuals to reduce their attention towards threat will be tested, with a focus on understanding the aspects of brain function that predict response to the treatment. This work could ultimately lead to the ability to treat anxiety more effectively by directly targeting the aspects of brain function that are altered in a given patient.
Age
18 - 55 years
Sex
ALL
Healthy Volunteers
No
University of Pittsburgh Department of Psychiatry
Pittsburgh, Pennsylvania, United States
Start Date
April 1, 2013
Primary Completion Date
January 1, 2017
Completion Date
January 1, 2018
Last Updated
March 8, 2018
70
ACTUAL participants
Attention Bias Modification
BEHAVIORAL
Neutral Training
BEHAVIORAL
Lead Sponsor
University of Pittsburgh
Collaborators
NCT07478393
NCT07456631
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions